Acarix investor relations material

Acarix AB, a medical technology company, provides revolutionary diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company develops the CADScor System to overcome the weaknesses of current non-invasive cardiac risk tests and offers a new ultra-sensitive analytical device for the diagnosis of coronary artery disease (CAD).